In adaptive immunity, B cells are architects of humoral defense. Their journey from naรฏve B cell to antibody-secreting plasma cell is highly regulated. 

๐—™๐—ฟ๐—ผ๐—บย ๐—”๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ปย ๐˜๐—ผย ๐—ฃ๐—น๐—ฎ๐˜€๐—บ๐—ฎย ๐—–๐—ฒ๐—น๐—น๐˜€ย 
๐˜ˆ๐˜ฏ๐˜ต๐˜ช๐˜จ๐˜ฆ๐˜ฏย ๐˜Œ๐˜ฏ๐˜ค๐˜ฐ๐˜ถ๐˜ฏ๐˜ต๐˜ฆ๐˜ณย Naรฏve B cells recognize native antigen via their B cell receptor (BCR), often internalizing and presenting fragments to helper T cells [1].ย 

๐˜›ย ๐˜Š๐˜ฆ๐˜ญ๐˜ญย ๐˜๐˜ฆ๐˜ญ๐˜ฑย  CD4โบย T follicular helper cells provide critical co-stimulation through CD40โ€“CD40L interactions and cytokines (IL-4, IL-21), driving B cell proliferation and class switching [2].ย 

๐˜Ž๐˜ฆ๐˜ณ๐˜ฎ๐˜ช๐˜ฏ๐˜ข๐˜ญย ๐˜Š๐˜ฆ๐˜ฏ๐˜ต๐˜ฆ๐˜ณย ๐˜™๐˜ฆ๐˜ข๐˜ค๐˜ต๐˜ช๐˜ฐ๐˜ฏย  Within secondary lymphoid tissues, B cells undergo somatic hypermutation and affinity maturation, refining their antibody specificity.ย 

๐˜‹๐˜ช๐˜ง๐˜ง๐˜ฆ๐˜ณ๐˜ฆ๐˜ฏ๐˜ต๐˜ช๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏย  The outcome is either long-lived plasma cells, producing antibodies for years, or memory B cells, ensuring rapid responses upon re-exposure.ย 

๐—š๐—ฒ๐—ฟ๐—บ๐—ฎ๐—ปย ๐—–๐—ผ๐—ป๐˜๐—ฟ๐—ถ๐—ฏ๐˜‚๐˜๐—ถ๐—ผ๐—ป๐˜€ย 
Thomas Winkler (Erlangen): Investigated genetic recombination processes essential for B cell receptor diversity [3].ย 
Heddaย Wardemannย (Heidelberg): Focuses on B cell fate decisions during vaccination,ย providingย key insights into germinal center andย plasmablastย responses [4].ย 
Klausย Rajewskyย (Berlin): Pioneered conditional knockout mouse models to study B cell biology and germinal center dynamics [5].ย 

๐—•ย ๐—–๐—ฒ๐—น๐—น๐˜€ย ๐—ถ๐—ปย ๐—œ๐—บ๐—บ๐˜‚๐—ป๐—ผ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐˜†ย 
Engineered B cells could, in theory, serve as ยดliving antibody factoriesยด, and currently engineered as monoclonals andย bispecifics.ย 

๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐˜‚๐—น๐—ฎ๐˜๐—ถ๐˜ƒ๐—ฒย ๐—›๐˜†๐—ฝ๐—ผ๐˜๐—ต๐—ฒ๐˜€๐—ถ๐˜€ย 
If CAR-T and CAR-NK represent cellular ยดweaponsยด, could CAR-B cells be engineered as modular antibody factories, secreting highly specific immunoglobulins directly in patients? Such a strategy mightย ๐˜ฃ๐˜บ๐˜ฑ๐˜ข๐˜ด๐˜ดย ๐˜ณ๐˜ฆ๐˜ฑ๐˜ฆ๐˜ข๐˜ต๐˜ฆ๐˜ฅย ๐˜ข๐˜ฏ๐˜ต๐˜ช๐˜ฃ๐˜ฐ๐˜ฅ๐˜บย ๐˜ช๐˜ฏ๐˜ง๐˜ถ๐˜ด๐˜ช๐˜ฐ๐˜ฏ๐˜ดย ๐˜ข๐˜ฏ๐˜ฅย ๐˜ค๐˜ณ๐˜ฆ๐˜ข๐˜ต๐˜ฆย ๐˜ขย ๐˜ด๐˜ฆ๐˜ญ๐˜ง-๐˜ณ๐˜ฆ๐˜ฏ๐˜ฆ๐˜ธ๐˜ช๐˜ฏ๐˜จย ๐˜ต๐˜ฉ๐˜ฆ๐˜ณ๐˜ข๐˜ฑ๐˜ฆ๐˜ถ๐˜ต๐˜ช๐˜คย ๐˜ณ๐˜ฆ๐˜ด๐˜ฆ๐˜ณ๐˜ท๐˜ฐ๐˜ช๐˜ณ.ย 

Stay tuned for ๐——๐—ฎ๐˜† ๐Ÿญ๐Ÿฒ: ๐—ง ๐—›๐—ฒ๐—น๐—ฝ๐—ฒ๐—ฟ (๐—–๐——๐Ÿฐ+) ๐—–๐—ฒ๐—น๐—น๐˜€: ๐—–๐—ผ๐—ป๐—ฑ๐˜‚๐—ฐ๐˜๐—ผ๐—ฟ๐˜€ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—œ๐—บ๐—บ๐˜‚๐—ป๐—ฒ ๐—ข๐—ฟ๐—ฐ๐—ต๐—ฒ๐˜€๐˜๐—ฟ๐—ฎ 

๐—ฅ๐—ฒ๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ป๐—ฐ๐—ฒ๐˜€ย 
1. DOI:โ€ฏ10.1038/nri2454ย 
2. DOI:โ€ฏ10.1146/annurev-immunol-031210-101400ย 
3.ย https://www.ncbi.nlm.nih.gov/books/NBK27113/ย 
4.ย https://www.dkfz.de/en/b-cell-immunologyย 
5.ย https://doi.org/10.1172/JCI118828ย โ€ฏย 

#100DaysOfImmunology #BCells #Antibodies #PlasmaCells #AdaptiveImmunity #GermanImmunology #Immunotherapy #CARBcells #HumoralImmunityย โ€ฏย